United States Pharma Sustained Release Excipient Market was valued at USD 1.8 Billion in 2022 and is projected to reach USD 2.9 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030.
The US Pharma Sustained Release Excipient Market plays a pivotal role in the pharmaceutical industry, ensuring that active ingredients are delivered gradually to the body over an extended period. This type of excipient helps in formulating drugs that release their active ingredients slowly, thereby reducing the frequency of administration and enhancing patient compliance. The sustained release excipients market has seen significant growth due to its potential to improve the efficacy of various therapeutic drugs.
One of the primary types of excipients used in sustained release formulations is hydrophilic polymers, which control the drug release rate. Other types include lipids, waxes, and inorganic materials, each serving specific roles in managing the drug release kinetics. Hydrophilic excipients are particularly favored for their ability to modify the drug release profile without compromising the drug’s bioavailability.
Pharma Sustained Release Excipient Market is highly influenced by the demands of various industries, especially the pharmaceutical and biotechnology sectors. These excipients are required not only to control the drug release rate but also to enhance stability, solubility, and bioavailability. Pharmaceutical companies increasingly rely on these excipients to develop more patient-friendly dosage forms, such as once-daily oral tablets, reducing the burden of frequent dosing.
From a regulatory standpoint, sustained release excipients must meet rigorous standards for quality, purity, and performance. The growing trend of personalized medicine, along with an increasing number of chronic diseases, is driving demand for excipients that can enable customized drug delivery. As drug formulations evolve, the Pharma Sustained Release Excipient Market must adapt to cater to the more complex requirements of these advanced therapies.
The need for innovation in excipient technology is particularly critical for industries focusing on improving the therapeutic outcomes of complex drugs. Pharma companies are investing heavily in research and development to optimize the functionality of excipients, ensuring that the drugs are not only effective but also safe and convenient for patients. This dynamic market continues to expand, fueled by the increasing preference for controlled drug delivery systems that can ensure consistent therapeutic effects while minimizing side effects.
Get an In-Depth Research Analysis of the US Pharma Sustained Release Excipient Market Size And Forecast [2025-2032]
Â
Teva Pharmaceutical Industries
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer
Sun Pharmaceutical Industries
Novartis AG
AstraZeneca
GlaxoSmithKline
Allergan
Janssen Pharmaceuticals
Mayne Pharma Group
BASF
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Pharma Sustained Release Excipient Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Pharma Sustained Release Excipient Market
Polymers
Sugars
Fatty Acids
Cross-Linked Agents
Natural Gums and Mucilages
Release Modifiers
Binders
Fillers
Coating Agents
Stabilizers
Oral Sustained Release
Injectable Sustained Release
Topical Sustained Release
Transdermal Systems
Ocular Formulations
Pharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Research Institutions
Government and Regulatory Bodies
Academic Institutions
Chronic Disease Management
Pain Management
Cancer Treatment
Cardiovascular Health
Neurological Disorders
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Pharma Sustained Release Excipient Market Research Analysis
1. Introduction of the US Pharma Sustained Release Excipient Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Pharma Sustained Release Excipient Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Pharma Sustained Release Excipient Market, By Type
6. US Pharma Sustained Release Excipient Market, By Application
7. US Pharma Sustained Release Excipient Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Pharma Sustained Release Excipient Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/